nodes	percent_of_prediction	percent_of_DWPC	metapath
Paroxetine—TACR1—hypertension	0.151	0.424	CbGaD
Paroxetine—SLC6A2—hypertension	0.0941	0.264	CbGaD
Paroxetine—SLC6A3—hypertension	0.0479	0.134	CbGaD
Paroxetine—SLC6A4—hypertension	0.0358	0.101	CbGaD
Paroxetine—SLC6A2—Guanadrel—hypertension	0.0275	0.0758	CbGbCtD
Paroxetine—HTR2A—hypertension	0.0275	0.0773	CbGaD
Paroxetine—SLC6A2—Guanethidine—hypertension	0.0209	0.0575	CbGbCtD
Paroxetine—CHRM4—Nicardipine—hypertension	0.0123	0.0338	CbGbCtD
Paroxetine—CHRM5—Nicardipine—hypertension	0.012	0.033	CbGbCtD
Paroxetine—CHRM3—Nicardipine—hypertension	0.00767	0.0211	CbGbCtD
Paroxetine—CYP2C8—Torasemide—hypertension	0.0068	0.0187	CbGbCtD
Paroxetine—CHRM1—Nicardipine—hypertension	0.00667	0.0184	CbGbCtD
Paroxetine—SLC6A2—Clonidine—hypertension	0.00657	0.0181	CbGbCtD
Paroxetine—CYP2C8—Candesartan—hypertension	0.00632	0.0174	CbGbCtD
Paroxetine—CHRM2—Nicardipine—hypertension	0.00615	0.0169	CbGbCtD
Paroxetine—CYP2C9—Eprosartan—hypertension	0.00582	0.016	CbGbCtD
Paroxetine—SLC6A4—Verapamil—hypertension	0.00565	0.0156	CbGbCtD
Paroxetine—CYP2B6—Amlodipine—hypertension	0.00506	0.0139	CbGbCtD
Paroxetine—ABCB1—Nadolol—hypertension	0.00503	0.0139	CbGbCtD
Paroxetine—CYP2C8—Diltiazem—hypertension	0.00479	0.0132	CbGbCtD
Paroxetine—CYP2C9—Torasemide—hypertension	0.00474	0.0131	CbGbCtD
Paroxetine—CYP2D6—Labetalol—hypertension	0.00474	0.0131	CbGbCtD
Paroxetine—CYP2D6—Nebivolol—hypertension	0.00474	0.0131	CbGbCtD
Paroxetine—CYP2B6—Nifedipine—hypertension	0.00472	0.013	CbGbCtD
Paroxetine—CYP2B6—Nicardipine—hypertension	0.00464	0.0128	CbGbCtD
Paroxetine—ABCB1—Acebutolol—hypertension	0.0046	0.0127	CbGbCtD
Paroxetine—CYP2C9—Guanfacine—hypertension	0.00441	0.0121	CbGbCtD
Paroxetine—CYP2C9—Candesartan—hypertension	0.00441	0.0121	CbGbCtD
Paroxetine—CYP2D6—Acebutolol—hypertension	0.00434	0.0119	CbGbCtD
Paroxetine—ABCB1—Candesartan—hypertension	0.00428	0.0118	CbGbCtD
Paroxetine—ABCB1—Metoprolol—hypertension	0.00428	0.0118	CbGbCtD
Paroxetine—CYP2D6—Pindolol—hypertension	0.00403	0.0111	CbGbCtD
Paroxetine—CYP2D6—Metoprolol—hypertension	0.00403	0.0111	CbGbCtD
Paroxetine—ABCB1—Terazosin—hypertension	0.00402	0.0111	CbGbCtD
Paroxetine—CYP2C8—Irbesartan—hypertension	0.00391	0.0108	CbGbCtD
Paroxetine—CYP2C8—Amlodipine—hypertension	0.00383	0.0105	CbGbCtD
Paroxetine—ABCB1—Reserpine—hypertension	0.00382	0.0105	CbGbCtD
Paroxetine—TACR1—vagus nerve—hypertension	0.0038	0.126	CbGeAlD
Paroxetine—CYP2C8—Spironolactone—hypertension	0.00376	0.0104	CbGbCtD
Paroxetine—CYP2C8—Felodipine—hypertension	0.00369	0.0102	CbGbCtD
Paroxetine—CYP2B6—Atorvastatin—hypertension	0.00363	0.01	CbGbCtD
Paroxetine—CYP2D6—Betaxolol—hypertension	0.00359	0.00989	CbGbCtD
Paroxetine—CYP2C8—Nifedipine—hypertension	0.00357	0.00984	CbGbCtD
Paroxetine—CYP2C8—Nicardipine—hypertension	0.00352	0.00968	CbGbCtD
Paroxetine—ABCB1—Perindopril—hypertension	0.00349	0.0096	CbGbCtD
Paroxetine—ABCB1—Nisoldipine—hypertension	0.00336	0.00925	CbGbCtD
Paroxetine—ABCB1—Doxazosin—hypertension	0.00336	0.00925	CbGbCtD
Paroxetine—CYP2C9—Diltiazem—hypertension	0.00334	0.0092	CbGbCtD
Paroxetine—ABCB1—Diltiazem—hypertension	0.00324	0.00893	CbGbCtD
Paroxetine—CYP2D6—Doxazosin—hypertension	0.00316	0.00871	CbGbCtD
Paroxetine—CYP2C9—Valsartan—hypertension	0.00306	0.00842	CbGbCtD
Paroxetine—CYP2D6—Diltiazem—hypertension	0.00306	0.00841	CbGbCtD
Paroxetine—ABCB1—Telmisartan—hypertension	0.00305	0.0084	CbGbCtD
Paroxetine—CYP2B6—Verapamil—hypertension	0.00293	0.00807	CbGbCtD
Paroxetine—ABCB1—Enalapril—hypertension	0.00289	0.00796	CbGbCtD
Paroxetine—ABCB1—Bepridil—hypertension	0.00289	0.00796	CbGbCtD
Paroxetine—ABCB1—Lisinopril—hypertension	0.00289	0.00796	CbGbCtD
Paroxetine—ABCB1—Prazosin—hypertension	0.00276	0.00759	CbGbCtD
Paroxetine—CYP2C8—Atorvastatin—hypertension	0.00275	0.00758	CbGbCtD
Paroxetine—CYP2C9—Irbesartan—hypertension	0.00272	0.0075	CbGbCtD
Paroxetine—CYP2D6—Bepridil—hypertension	0.00272	0.0075	CbGbCtD
Paroxetine—CYP2C9—Amlodipine—hypertension	0.00267	0.00736	CbGbCtD
Paroxetine—ABCB1—Amlodipine—hypertension	0.00259	0.00714	CbGbCtD
Paroxetine—CYP2C9—Felodipine—hypertension	0.00258	0.00709	CbGbCtD
Paroxetine—ABCB1—Spironolactone—hypertension	0.00255	0.00701	CbGbCtD
Paroxetine—CYP2C8—Losartan—hypertension	0.00252	0.00693	CbGbCtD
Paroxetine—ABCB1—Felodipine—hypertension	0.0025	0.00688	CbGbCtD
Paroxetine—CYP2C9—Nifedipine—hypertension	0.00249	0.00686	CbGbCtD
Paroxetine—CYP2D6—Irbesartan—hypertension	0.00249	0.00686	CbGbCtD
Paroxetine—ABCB1—Timolol—hypertension	0.00246	0.00677	CbGbCtD
Paroxetine—CYP2C9—Nicardipine—hypertension	0.00245	0.00675	CbGbCtD
Paroxetine—CYP2C9—Carvedilol—hypertension	0.00245	0.00675	CbGbCtD
Paroxetine—CYP2D6—Amlodipine—hypertension	0.00244	0.00673	CbGbCtD
Paroxetine—ABCB1—Nifedipine—hypertension	0.00242	0.00666	CbGbCtD
Paroxetine—ABCB1—Nicardipine—hypertension	0.00238	0.00655	CbGbCtD
Paroxetine—ABCB1—Carvedilol—hypertension	0.00238	0.00655	CbGbCtD
Paroxetine—CYP2D6—Felodipine—hypertension	0.00236	0.00649	CbGbCtD
Paroxetine—CYP2D6—Timolol—hypertension	0.00232	0.00638	CbGbCtD
Paroxetine—CYP2D6—Nifedipine—hypertension	0.00228	0.00627	CbGbCtD
Paroxetine—CYP2D6—Carvedilol—hypertension	0.00224	0.00618	CbGbCtD
Paroxetine—CYP2D6—Nicardipine—hypertension	0.00224	0.00618	CbGbCtD
Paroxetine—CYP2C8—Verapamil—hypertension	0.00222	0.00612	CbGbCtD
Paroxetine—ABCB1—Propranolol—hypertension	0.00219	0.00603	CbGbCtD
Paroxetine—ABCB1—Captopril—hypertension	0.00216	0.00596	CbGbCtD
Paroxetine—ABCB1—Clonidine—hypertension	0.00209	0.00575	CbGbCtD
Paroxetine—CYP2D6—Propranolol—hypertension	0.00206	0.00568	CbGbCtD
Paroxetine—CYP2D6—Captopril—hypertension	0.00204	0.00561	CbGbCtD
Paroxetine—SLC6A2—locus ceruleus—hypertension	0.00202	0.0666	CbGeAlD
Paroxetine—CYP2D6—Clonidine—hypertension	0.00197	0.00542	CbGbCtD
Paroxetine—CYP2C9—Atorvastatin—hypertension	0.00192	0.00528	CbGbCtD
Paroxetine—ABCB1—Atorvastatin—hypertension	0.00186	0.00513	CbGbCtD
Paroxetine—CYP2C9—Losartan—hypertension	0.00176	0.00483	CbGbCtD
Paroxetine—CYP2D6—Atorvastatin—hypertension	0.00176	0.00483	CbGbCtD
Paroxetine—ABCB1—Losartan—hypertension	0.0017	0.00469	CbGbCtD
Paroxetine—SLC6A2—sympathetic nervous system—hypertension	0.00159	0.0526	CbGeAlD
Paroxetine—CYP2C9—Verapamil—hypertension	0.00155	0.00427	CbGbCtD
Paroxetine—ABCB1—Verapamil—hypertension	0.0015	0.00414	CbGbCtD
Paroxetine—HTR2A—arteriole—hypertension	0.0015	0.0496	CbGeAlD
Paroxetine—CYP2D6—Verapamil—hypertension	0.00142	0.0039	CbGbCtD
Paroxetine—HTR2A—locus ceruleus—hypertension	0.00121	0.04	CbGeAlD
Paroxetine—SLC6A2—autonomic nervous system—hypertension	0.00107	0.0354	CbGeAlD
Paroxetine—HTR2A—pulmonary artery—hypertension	0.000985	0.0325	CbGeAlD
Paroxetine—HTR2A—sympathetic nervous system—hypertension	0.000958	0.0316	CbGeAlD
Paroxetine—HTR2A—vagus nerve—hypertension	0.000927	0.0306	CbGeAlD
Paroxetine—HTR2A—vein—hypertension	0.000896	0.0296	CbGeAlD
Paroxetine—HTR2A—autonomic nervous system—hypertension	0.000644	0.0213	CbGeAlD
Paroxetine—TACR1—brainstem—hypertension	0.000637	0.021	CbGeAlD
Paroxetine—CYP2C9—urine—hypertension	0.000637	0.021	CbGeAlD
Paroxetine—HTR2A—hindlimb—hypertension	0.000595	0.0197	CbGeAlD
Paroxetine—TACR1—smooth muscle tissue—hypertension	0.000547	0.0181	CbGeAlD
Paroxetine—HTR2A—urine—hypertension	0.000525	0.0173	CbGeAlD
Paroxetine—CYP2D6—urine—hypertension	0.000478	0.0158	CbGeAlD
Paroxetine—TACR1—adrenal gland—hypertension	0.000411	0.0136	CbGeAlD
Paroxetine—HTR2A—artery—hypertension	0.000365	0.0121	CbGeAlD
Paroxetine—TACR1—endocrine gland—hypertension	0.000357	0.0118	CbGeAlD
Paroxetine—TACR1—central nervous system—hypertension	0.000321	0.0106	CbGeAlD
Paroxetine—SLC6A3—brainstem—hypertension	0.000321	0.0106	CbGeAlD
Paroxetine—HTR2A—endothelium—hypertension	0.000308	0.0102	CbGeAlD
Paroxetine—CHRM4—central nervous system—hypertension	0.000302	0.00998	CbGeAlD
Paroxetine—SLC6A4—brainstem—hypertension	0.000294	0.0097	CbGeAlD
Paroxetine—HTR2A—blood vessel—hypertension	0.000284	0.00939	CbGeAlD
Paroxetine—CHRM2—heart—hypertension	0.000278	0.00918	CbGeAlD
Paroxetine—CHRM2—cardiovascular system—hypertension	0.000262	0.00866	CbGeAlD
Paroxetine—SLC6A2—brainstem—hypertension	0.000259	0.00854	CbGeAlD
Paroxetine—CHRM1—cardiovascular system—hypertension	0.000239	0.00789	CbGeAlD
Paroxetine—CHRM5—central nervous system—hypertension	0.000236	0.0078	CbGeAlD
Paroxetine—CHRM3—smooth muscle tissue—hypertension	0.000225	0.00742	CbGeAlD
Paroxetine—SLC6A2—decidua—hypertension	0.000218	0.00718	CbGeAlD
Paroxetine—CHRM3—kidney—hypertension	0.000209	0.0069	CbGeAlD
Paroxetine—ABCB1—blood vessel—hypertension	0.000186	0.00615	CbGeAlD
Paroxetine—SLC6A2—medulla oblongata—hypertension	0.00018	0.00595	CbGeAlD
Paroxetine—CHRM2—endocrine gland—hypertension	0.00018	0.00594	CbGeAlD
Paroxetine—CYP2B6—nephron tubule—hypertension	0.000173	0.00572	CbGeAlD
Paroxetine—CYP2B6—adrenal cortex—hypertension	0.00017	0.00563	CbGeAlD
Paroxetine—CYP2C8—kidney—hypertension	0.00017	0.0056	CbGeAlD
Paroxetine—SLC6A2—adrenal gland—hypertension	0.000167	0.00551	CbGeAlD
Paroxetine—CYP2B6—heart—hypertension	0.000165	0.00544	CbGeAlD
Paroxetine—SLC6A4—endocrine gland—hypertension	0.000164	0.00543	CbGeAlD
Paroxetine—CHRM1—endocrine gland—hypertension	0.000164	0.00541	CbGeAlD
Paroxetine—CYP2C9—heart—hypertension	0.000163	0.00539	CbGeAlD
Paroxetine—CHRM2—central nervous system—hypertension	0.000162	0.00535	CbGeAlD
Paroxetine—SLC6A3—central nervous system—hypertension	0.000162	0.00534	CbGeAlD
Paroxetine—CYP2B6—cardiovascular system—hypertension	0.000156	0.00514	CbGeAlD
Paroxetine—HTR2A—brainstem—hypertension	0.000155	0.00513	CbGeAlD
Paroxetine—CYP2C9—cardiovascular system—hypertension	0.000154	0.00509	CbGeAlD
Paroxetine—CYP2B6—kidney—hypertension	0.000152	0.00502	CbGeAlD
Paroxetine—SLC6A4—central nervous system—hypertension	0.000148	0.00489	CbGeAlD
Paroxetine—CHRM1—central nervous system—hypertension	0.000148	0.00487	CbGeAlD
Paroxetine—CHRM3—endocrine gland—hypertension	0.000147	0.00484	CbGeAlD
Paroxetine—SLC6A2—endocrine gland—hypertension	0.000145	0.00478	CbGeAlD
Paroxetine—CYP2D6—brainstem—hypertension	0.000142	0.00468	CbGeAlD
Paroxetine—HTR2A—heart—hypertension	0.000134	0.00444	CbGeAlD
Paroxetine—HTR2A—smooth muscle tissue—hypertension	0.000133	0.0044	CbGeAlD
Paroxetine—CHRM3—central nervous system—hypertension	0.000132	0.00436	CbGeAlD
Paroxetine—SLC6A2—central nervous system—hypertension	0.00013	0.00431	CbGeAlD
Paroxetine—HTR2A—cardiovascular system—hypertension	0.000127	0.00419	CbGeAlD
Paroxetine—HTR2A—kidney—hypertension	0.000124	0.0041	CbGeAlD
Paroxetine—CYP2B6—adrenal gland—hypertension	0.000123	0.00406	CbGeAlD
Paroxetine—CYP2C8—endocrine gland—hypertension	0.000119	0.00393	CbGeAlD
Paroxetine—CYP2D6—kidney—hypertension	0.000113	0.00373	CbGeAlD
Paroxetine—HTR2A—medulla oblongata—hypertension	0.000108	0.00358	CbGeAlD
Paroxetine—CYP2B6—endocrine gland—hypertension	0.000107	0.00352	CbGeAlD
Paroxetine—CYP2C9—endocrine gland—hypertension	0.000106	0.00349	CbGeAlD
Paroxetine—HTR2A—adrenal gland—hypertension	0.0001	0.00331	CbGeAlD
Paroxetine—CYP2B6—central nervous system—hypertension	9.61e-05	0.00317	CbGeAlD
Paroxetine—ABCB1—nephron tubule—hypertension	9.25e-05	0.00306	CbGeAlD
Paroxetine—ABCB1—adrenal cortex—hypertension	9.11e-05	0.00301	CbGeAlD
Paroxetine—ABCB1—heart—hypertension	8.81e-05	0.00291	CbGeAlD
Paroxetine—HTR2A—endocrine gland—hypertension	8.7e-05	0.00287	CbGeAlD
Paroxetine—ABCB1—decidua—hypertension	8.57e-05	0.00283	CbGeAlD
Paroxetine—ABCB1—cardiovascular system—hypertension	8.31e-05	0.00275	CbGeAlD
Paroxetine—ABCB1—kidney—hypertension	8.13e-05	0.00269	CbGeAlD
Paroxetine—CYP2D6—endocrine gland—hypertension	7.93e-05	0.00262	CbGeAlD
Paroxetine—ABCB1—cortex of kidney—hypertension	7.92e-05	0.00262	CbGeAlD
Paroxetine—HTR2A—central nervous system—hypertension	7.84e-05	0.00259	CbGeAlD
Paroxetine—CYP2D6—central nervous system—hypertension	7.14e-05	0.00236	CbGeAlD
Paroxetine—ABCB1—medulla oblongata—hypertension	7.1e-05	0.00235	CbGeAlD
Paroxetine—ABCB1—adrenal gland—hypertension	6.57e-05	0.00217	CbGeAlD
Paroxetine—ABCB1—endocrine gland—hypertension	5.7e-05	0.00188	CbGeAlD
Paroxetine—ABCB1—central nervous system—hypertension	5.14e-05	0.0017	CbGeAlD
Paroxetine—Body temperature increased—Irbesartan—hypertension	8.17e-06	5.12e-05	CcSEcCtD
Paroxetine—Thrombocytopenia—Ramipril—hypertension	8.17e-06	5.12e-05	CcSEcCtD
Paroxetine—Oedema—Timolol—hypertension	8.16e-06	5.11e-05	CcSEcCtD
Paroxetine—Anaphylactic shock—Timolol—hypertension	8.16e-06	5.11e-05	CcSEcCtD
Paroxetine—Loss of consciousness—Lisinopril—hypertension	8.15e-06	5.11e-05	CcSEcCtD
Paroxetine—Rash—Verapamil—hypertension	8.15e-06	5.11e-05	CcSEcCtD
Paroxetine—Urticaria—Hydrochlorothiazide—hypertension	8.15e-06	5.1e-05	CcSEcCtD
Paroxetine—Tachycardia—Ramipril—hypertension	8.14e-06	5.1e-05	CcSEcCtD
Paroxetine—Dermatitis—Verapamil—hypertension	8.14e-06	5.1e-05	CcSEcCtD
Paroxetine—Headache—Nifedipine—hypertension	8.13e-06	5.09e-05	CcSEcCtD
Paroxetine—Pruritus—Clonidine—hypertension	8.11e-06	5.08e-05	CcSEcCtD
Paroxetine—Abdominal pain—Hydrochlorothiazide—hypertension	8.11e-06	5.08e-05	CcSEcCtD
Paroxetine—Body temperature increased—Hydrochlorothiazide—hypertension	8.11e-06	5.08e-05	CcSEcCtD
Paroxetine—Skin disorder—Ramipril—hypertension	8.1e-06	5.08e-05	CcSEcCtD
Paroxetine—Infection—Timolol—hypertension	8.1e-06	5.08e-05	CcSEcCtD
Paroxetine—Headache—Verapamil—hypertension	8.1e-06	5.07e-05	CcSEcCtD
Paroxetine—Hypersensitivity—Telmisartan—hypertension	8.1e-06	5.07e-05	CcSEcCtD
Paroxetine—Cough—Lisinopril—hypertension	8.09e-06	5.07e-05	CcSEcCtD
Paroxetine—Nausea—Diltiazem—hypertension	8.08e-06	5.06e-05	CcSEcCtD
Paroxetine—Nausea—Indapamide—hypertension	8.08e-06	5.06e-05	CcSEcCtD
Paroxetine—Hyperhidrosis—Ramipril—hypertension	8.07e-06	5.05e-05	CcSEcCtD
Paroxetine—Asthenia—Trandolapril—hypertension	8.03e-06	5.03e-05	CcSEcCtD
Paroxetine—Shock—Timolol—hypertension	8.03e-06	5.03e-05	CcSEcCtD
Paroxetine—Feeling abnormal—Losartan—hypertension	8.02e-06	5.02e-05	CcSEcCtD
Paroxetine—Urticaria—Furosemide—hypertension	8.01e-06	5.02e-05	CcSEcCtD
Paroxetine—Nervous system disorder—Timolol—hypertension	8e-06	5.01e-05	CcSEcCtD
Paroxetine—Nausea—Carvedilol—hypertension	8e-06	5.01e-05	CcSEcCtD
Paroxetine—Asthenia—Enalapril—hypertension	7.99e-06	5.01e-05	CcSEcCtD
Paroxetine—Abdominal pain—Furosemide—hypertension	7.97e-06	4.99e-05	CcSEcCtD
Paroxetine—Body temperature increased—Furosemide—hypertension	7.97e-06	4.99e-05	CcSEcCtD
Paroxetine—Gastrointestinal pain—Losartan—hypertension	7.96e-06	4.99e-05	CcSEcCtD
Paroxetine—Dizziness—Valsartan—hypertension	7.96e-06	4.98e-05	CcSEcCtD
Paroxetine—Urticaria—Betaxolol—hypertension	7.93e-06	4.97e-05	CcSEcCtD
Paroxetine—Skin disorder—Timolol—hypertension	7.92e-06	4.96e-05	CcSEcCtD
Paroxetine—Dizziness—Olmesartan—hypertension	7.92e-06	4.96e-05	CcSEcCtD
Paroxetine—Pruritus—Trandolapril—hypertension	7.91e-06	4.96e-05	CcSEcCtD
Paroxetine—Nausea—Doxazosin—hypertension	7.91e-06	4.96e-05	CcSEcCtD
Paroxetine—Chest pain—Lisinopril—hypertension	7.89e-06	4.95e-05	CcSEcCtD
Paroxetine—Arthralgia—Lisinopril—hypertension	7.89e-06	4.95e-05	CcSEcCtD
Paroxetine—Myalgia—Lisinopril—hypertension	7.89e-06	4.95e-05	CcSEcCtD
Paroxetine—Body temperature increased—Betaxolol—hypertension	7.89e-06	4.95e-05	CcSEcCtD
Paroxetine—Hyperhidrosis—Timolol—hypertension	7.89e-06	4.94e-05	CcSEcCtD
Paroxetine—Asthenia—Telmisartan—hypertension	7.88e-06	4.94e-05	CcSEcCtD
Paroxetine—Pruritus—Enalapril—hypertension	7.88e-06	4.94e-05	CcSEcCtD
Paroxetine—Anxiety—Lisinopril—hypertension	7.87e-06	4.93e-05	CcSEcCtD
Paroxetine—Diarrhoea—Clonidine—hypertension	7.85e-06	4.92e-05	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	7.84e-06	4.91e-05	CcSEcCtD
Paroxetine—Nausea—Fosinopril—hypertension	7.81e-06	4.9e-05	CcSEcCtD
Paroxetine—Discomfort—Lisinopril—hypertension	7.8e-06	4.89e-05	CcSEcCtD
Paroxetine—Hypotension—Ramipril—hypertension	7.8e-06	4.88e-05	CcSEcCtD
Paroxetine—Pruritus—Telmisartan—hypertension	7.77e-06	4.87e-05	CcSEcCtD
Paroxetine—Nausea—Eplerenone—hypertension	7.77e-06	4.87e-05	CcSEcCtD
Paroxetine—Urticaria—Losartan—hypertension	7.73e-06	4.84e-05	CcSEcCtD
Paroxetine—Dry mouth—Lisinopril—hypertension	7.72e-06	4.84e-05	CcSEcCtD
Paroxetine—Nausea—Nifedipine—hypertension	7.71e-06	4.83e-05	CcSEcCtD
Paroxetine—Body temperature increased—Losartan—hypertension	7.69e-06	4.82e-05	CcSEcCtD
Paroxetine—Abdominal pain—Losartan—hypertension	7.69e-06	4.82e-05	CcSEcCtD
Paroxetine—Nausea—Verapamil—hypertension	7.68e-06	4.81e-05	CcSEcCtD
Paroxetine—Asthenia—Captopril—hypertension	7.67e-06	4.8e-05	CcSEcCtD
Paroxetine—Diarrhoea—Trandolapril—hypertension	7.65e-06	4.79e-05	CcSEcCtD
Paroxetine—Vomiting—Valsartan—hypertension	7.65e-06	4.79e-05	CcSEcCtD
Paroxetine—Confusional state—Lisinopril—hypertension	7.63e-06	4.78e-05	CcSEcCtD
Paroxetine—Diarrhoea—Enalapril—hypertension	7.62e-06	4.78e-05	CcSEcCtD
Paroxetine—Hypotension—Timolol—hypertension	7.62e-06	4.78e-05	CcSEcCtD
Paroxetine—Hypersensitivity—Irbesartan—hypertension	7.62e-06	4.77e-05	CcSEcCtD
Paroxetine—Vomiting—Olmesartan—hypertension	7.61e-06	4.77e-05	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Ramipril—hypertension	7.6e-06	4.76e-05	CcSEcCtD
Paroxetine—Rash—Valsartan—hypertension	7.59e-06	4.75e-05	CcSEcCtD
Paroxetine—Dizziness—Clonidine—hypertension	7.58e-06	4.75e-05	CcSEcCtD
Paroxetine—Dermatitis—Valsartan—hypertension	7.58e-06	4.75e-05	CcSEcCtD
Paroxetine—Anaphylactic shock—Lisinopril—hypertension	7.57e-06	4.74e-05	CcSEcCtD
Paroxetine—Oedema—Lisinopril—hypertension	7.57e-06	4.74e-05	CcSEcCtD
Paroxetine—Pruritus—Captopril—hypertension	7.56e-06	4.74e-05	CcSEcCtD
Paroxetine—Hypersensitivity—Hydrochlorothiazide—hypertension	7.56e-06	4.73e-05	CcSEcCtD
Paroxetine—Rash—Olmesartan—hypertension	7.55e-06	4.73e-05	CcSEcCtD
Paroxetine—Insomnia—Ramipril—hypertension	7.55e-06	4.73e-05	CcSEcCtD
Paroxetine—Dermatitis—Olmesartan—hypertension	7.54e-06	4.73e-05	CcSEcCtD
Paroxetine—Headache—Valsartan—hypertension	7.54e-06	4.72e-05	CcSEcCtD
Paroxetine—Diarrhoea—Telmisartan—hypertension	7.52e-06	4.71e-05	CcSEcCtD
Paroxetine—Infection—Lisinopril—hypertension	7.52e-06	4.71e-05	CcSEcCtD
Paroxetine—Headache—Olmesartan—hypertension	7.5e-06	4.7e-05	CcSEcCtD
Paroxetine—Paraesthesia—Ramipril—hypertension	7.49e-06	4.69e-05	CcSEcCtD
Paroxetine—Shock—Lisinopril—hypertension	7.45e-06	4.66e-05	CcSEcCtD
Paroxetine—Asthenia—Perindopril—hypertension	7.44e-06	4.66e-05	CcSEcCtD
Paroxetine—Dyspnoea—Ramipril—hypertension	7.44e-06	4.66e-05	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Timolol—hypertension	7.43e-06	4.66e-05	CcSEcCtD
Paroxetine—Hypersensitivity—Furosemide—hypertension	7.43e-06	4.66e-05	CcSEcCtD
Paroxetine—Asthenia—Irbesartan—hypertension	7.42e-06	4.65e-05	CcSEcCtD
Paroxetine—Somnolence—Ramipril—hypertension	7.42e-06	4.65e-05	CcSEcCtD
Paroxetine—Thrombocytopenia—Lisinopril—hypertension	7.41e-06	4.64e-05	CcSEcCtD
Paroxetine—Dizziness—Trandolapril—hypertension	7.4e-06	4.63e-05	CcSEcCtD
Paroxetine—Tachycardia—Lisinopril—hypertension	7.39e-06	4.63e-05	CcSEcCtD
Paroxetine—Insomnia—Timolol—hypertension	7.38e-06	4.62e-05	CcSEcCtD
Paroxetine—Dizziness—Enalapril—hypertension	7.37e-06	4.62e-05	CcSEcCtD
Paroxetine—Asthenia—Hydrochlorothiazide—hypertension	7.36e-06	4.61e-05	CcSEcCtD
Paroxetine—Hypersensitivity—Betaxolol—hypertension	7.36e-06	4.61e-05	CcSEcCtD
Paroxetine—Skin disorder—Lisinopril—hypertension	7.35e-06	4.6e-05	CcSEcCtD
Paroxetine—Dyspepsia—Ramipril—hypertension	7.35e-06	4.6e-05	CcSEcCtD
Paroxetine—Pruritus—Perindopril—hypertension	7.34e-06	4.6e-05	CcSEcCtD
Paroxetine—Paraesthesia—Timolol—hypertension	7.32e-06	4.59e-05	CcSEcCtD
Paroxetine—Pruritus—Irbesartan—hypertension	7.32e-06	4.58e-05	CcSEcCtD
Paroxetine—Hyperhidrosis—Lisinopril—hypertension	7.32e-06	4.58e-05	CcSEcCtD
Paroxetine—Diarrhoea—Captopril—hypertension	7.31e-06	4.58e-05	CcSEcCtD
Paroxetine—Vomiting—Clonidine—hypertension	7.29e-06	4.57e-05	CcSEcCtD
Paroxetine—Dyspnoea—Timolol—hypertension	7.27e-06	4.56e-05	CcSEcCtD
Paroxetine—Dizziness—Telmisartan—hypertension	7.27e-06	4.55e-05	CcSEcCtD
Paroxetine—Pruritus—Hydrochlorothiazide—hypertension	7.26e-06	4.55e-05	CcSEcCtD
Paroxetine—Decreased appetite—Ramipril—hypertension	7.25e-06	4.54e-05	CcSEcCtD
Paroxetine—Somnolence—Timolol—hypertension	7.25e-06	4.54e-05	CcSEcCtD
Paroxetine—Asthenia—Furosemide—hypertension	7.24e-06	4.53e-05	CcSEcCtD
Paroxetine—Rash—Clonidine—hypertension	7.23e-06	4.53e-05	CcSEcCtD
Paroxetine—Dermatitis—Clonidine—hypertension	7.22e-06	4.53e-05	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Ramipril—hypertension	7.2e-06	4.51e-05	CcSEcCtD
Paroxetine—Fatigue—Ramipril—hypertension	7.19e-06	4.51e-05	CcSEcCtD
Paroxetine—Headache—Clonidine—hypertension	7.19e-06	4.5e-05	CcSEcCtD
Paroxetine—Dyspepsia—Timolol—hypertension	7.18e-06	4.5e-05	CcSEcCtD
Paroxetine—Hypersensitivity—Losartan—hypertension	7.17e-06	4.49e-05	CcSEcCtD
Paroxetine—Asthenia—Betaxolol—hypertension	7.16e-06	4.49e-05	CcSEcCtD
Paroxetine—Nausea—Valsartan—hypertension	7.15e-06	4.48e-05	CcSEcCtD
Paroxetine—Pruritus—Furosemide—hypertension	7.14e-06	4.47e-05	CcSEcCtD
Paroxetine—Constipation—Ramipril—hypertension	7.14e-06	4.47e-05	CcSEcCtD
Paroxetine—Nausea—Olmesartan—hypertension	7.11e-06	4.46e-05	CcSEcCtD
Paroxetine—Vomiting—Trandolapril—hypertension	7.11e-06	4.46e-05	CcSEcCtD
Paroxetine—Diarrhoea—Perindopril—hypertension	7.1e-06	4.45e-05	CcSEcCtD
Paroxetine—Decreased appetite—Timolol—hypertension	7.09e-06	4.44e-05	CcSEcCtD
Paroxetine—Vomiting—Enalapril—hypertension	7.08e-06	4.44e-05	CcSEcCtD
Paroxetine—Diarrhoea—Irbesartan—hypertension	7.08e-06	4.43e-05	CcSEcCtD
Paroxetine—Hypotension—Lisinopril—hypertension	7.07e-06	4.43e-05	CcSEcCtD
Paroxetine—Dizziness—Captopril—hypertension	7.07e-06	4.43e-05	CcSEcCtD
Paroxetine—Pruritus—Betaxolol—hypertension	7.06e-06	4.43e-05	CcSEcCtD
Paroxetine—Rash—Trandolapril—hypertension	7.05e-06	4.42e-05	CcSEcCtD
Paroxetine—Dermatitis—Trandolapril—hypertension	7.05e-06	4.41e-05	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Timolol—hypertension	7.04e-06	4.41e-05	CcSEcCtD
Paroxetine—Fatigue—Timolol—hypertension	7.03e-06	4.41e-05	CcSEcCtD
Paroxetine—Rash—Enalapril—hypertension	7.02e-06	4.4e-05	CcSEcCtD
Paroxetine—Dermatitis—Enalapril—hypertension	7.02e-06	4.4e-05	CcSEcCtD
Paroxetine—Diarrhoea—Hydrochlorothiazide—hypertension	7.02e-06	4.4e-05	CcSEcCtD
Paroxetine—Headache—Trandolapril—hypertension	7.01e-06	4.39e-05	CcSEcCtD
Paroxetine—Vomiting—Telmisartan—hypertension	6.99e-06	4.38e-05	CcSEcCtD
Paroxetine—Asthenia—Losartan—hypertension	6.98e-06	4.37e-05	CcSEcCtD
Paroxetine—Headache—Enalapril—hypertension	6.98e-06	4.37e-05	CcSEcCtD
Paroxetine—Pain—Timolol—hypertension	6.98e-06	4.37e-05	CcSEcCtD
Paroxetine—Rash—Telmisartan—hypertension	6.93e-06	4.34e-05	CcSEcCtD
Paroxetine—Dermatitis—Telmisartan—hypertension	6.92e-06	4.34e-05	CcSEcCtD
Paroxetine—Diarrhoea—Furosemide—hypertension	6.9e-06	4.32e-05	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Lisinopril—hypertension	6.89e-06	4.32e-05	CcSEcCtD
Paroxetine—Pruritus—Losartan—hypertension	6.88e-06	4.31e-05	CcSEcCtD
Paroxetine—Headache—Telmisartan—hypertension	6.88e-06	4.31e-05	CcSEcCtD
Paroxetine—Feeling abnormal—Ramipril—hypertension	6.88e-06	4.31e-05	CcSEcCtD
Paroxetine—Dizziness—Perindopril—hypertension	6.86e-06	4.3e-05	CcSEcCtD
Paroxetine—Insomnia—Lisinopril—hypertension	6.84e-06	4.29e-05	CcSEcCtD
Paroxetine—Dizziness—Irbesartan—hypertension	6.84e-06	4.28e-05	CcSEcCtD
Paroxetine—Diarrhoea—Betaxolol—hypertension	6.83e-06	4.28e-05	CcSEcCtD
Paroxetine—Gastrointestinal pain—Ramipril—hypertension	6.82e-06	4.27e-05	CcSEcCtD
Paroxetine—Nausea—Clonidine—hypertension	6.81e-06	4.27e-05	CcSEcCtD
Paroxetine—Paraesthesia—Lisinopril—hypertension	6.8e-06	4.26e-05	CcSEcCtD
Paroxetine—Vomiting—Captopril—hypertension	6.79e-06	4.26e-05	CcSEcCtD
Paroxetine—Dizziness—Hydrochlorothiazide—hypertension	6.78e-06	4.25e-05	CcSEcCtD
Paroxetine—Dyspnoea—Lisinopril—hypertension	6.75e-06	4.23e-05	CcSEcCtD
Paroxetine—Rash—Captopril—hypertension	6.74e-06	4.22e-05	CcSEcCtD
Paroxetine—Dermatitis—Captopril—hypertension	6.73e-06	4.22e-05	CcSEcCtD
Paroxetine—Somnolence—Lisinopril—hypertension	6.73e-06	4.21e-05	CcSEcCtD
Paroxetine—Feeling abnormal—Timolol—hypertension	6.72e-06	4.21e-05	CcSEcCtD
Paroxetine—Headache—Captopril—hypertension	6.69e-06	4.19e-05	CcSEcCtD
Paroxetine—Gastrointestinal pain—Timolol—hypertension	6.67e-06	4.18e-05	CcSEcCtD
Paroxetine—Dizziness—Furosemide—hypertension	6.67e-06	4.18e-05	CcSEcCtD
Paroxetine—Dyspepsia—Lisinopril—hypertension	6.66e-06	4.17e-05	CcSEcCtD
Paroxetine—Diarrhoea—Losartan—hypertension	6.66e-06	4.17e-05	CcSEcCtD
Paroxetine—Nausea—Trandolapril—hypertension	6.64e-06	4.16e-05	CcSEcCtD
Paroxetine—Urticaria—Ramipril—hypertension	6.63e-06	4.15e-05	CcSEcCtD
Paroxetine—Nausea—Enalapril—hypertension	6.62e-06	4.15e-05	CcSEcCtD
Paroxetine—Dizziness—Betaxolol—hypertension	6.6e-06	4.14e-05	CcSEcCtD
Paroxetine—Vomiting—Perindopril—hypertension	6.6e-06	4.13e-05	CcSEcCtD
Paroxetine—Body temperature increased—Ramipril—hypertension	6.6e-06	4.13e-05	CcSEcCtD
Paroxetine—Abdominal pain—Ramipril—hypertension	6.6e-06	4.13e-05	CcSEcCtD
Paroxetine—Decreased appetite—Lisinopril—hypertension	6.58e-06	4.12e-05	CcSEcCtD
Paroxetine—Vomiting—Irbesartan—hypertension	6.57e-06	4.12e-05	CcSEcCtD
Paroxetine—Rash—Perindopril—hypertension	6.54e-06	4.1e-05	CcSEcCtD
Paroxetine—Dermatitis—Perindopril—hypertension	6.54e-06	4.09e-05	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Lisinopril—hypertension	6.53e-06	4.09e-05	CcSEcCtD
Paroxetine—Nausea—Telmisartan—hypertension	6.53e-06	4.09e-05	CcSEcCtD
Paroxetine—Fatigue—Lisinopril—hypertension	6.52e-06	4.09e-05	CcSEcCtD
Paroxetine—Vomiting—Hydrochlorothiazide—hypertension	6.52e-06	4.09e-05	CcSEcCtD
Paroxetine—Rash—Irbesartan—hypertension	6.52e-06	4.08e-05	CcSEcCtD
Paroxetine—Dermatitis—Irbesartan—hypertension	6.51e-06	4.08e-05	CcSEcCtD
Paroxetine—Headache—Perindopril—hypertension	6.5e-06	4.07e-05	CcSEcCtD
Paroxetine—Urticaria—Timolol—hypertension	6.48e-06	4.06e-05	CcSEcCtD
Paroxetine—Headache—Irbesartan—hypertension	6.48e-06	4.06e-05	CcSEcCtD
Paroxetine—Constipation—Lisinopril—hypertension	6.47e-06	4.05e-05	CcSEcCtD
Paroxetine—Pain—Lisinopril—hypertension	6.47e-06	4.05e-05	CcSEcCtD
Paroxetine—Rash—Hydrochlorothiazide—hypertension	6.47e-06	4.05e-05	CcSEcCtD
Paroxetine—Dermatitis—Hydrochlorothiazide—hypertension	6.46e-06	4.05e-05	CcSEcCtD
Paroxetine—Abdominal pain—Timolol—hypertension	6.45e-06	4.04e-05	CcSEcCtD
Paroxetine—Body temperature increased—Timolol—hypertension	6.45e-06	4.04e-05	CcSEcCtD
Paroxetine—Dizziness—Losartan—hypertension	6.44e-06	4.03e-05	CcSEcCtD
Paroxetine—Headache—Hydrochlorothiazide—hypertension	6.42e-06	4.03e-05	CcSEcCtD
Paroxetine—Vomiting—Furosemide—hypertension	6.41e-06	4.02e-05	CcSEcCtD
Paroxetine—Rash—Furosemide—hypertension	6.36e-06	3.98e-05	CcSEcCtD
Paroxetine—Dermatitis—Furosemide—hypertension	6.35e-06	3.98e-05	CcSEcCtD
Paroxetine—Vomiting—Betaxolol—hypertension	6.35e-06	3.98e-05	CcSEcCtD
Paroxetine—Nausea—Captopril—hypertension	6.35e-06	3.98e-05	CcSEcCtD
Paroxetine—Headache—Furosemide—hypertension	6.32e-06	3.96e-05	CcSEcCtD
Paroxetine—Rash—Betaxolol—hypertension	6.3e-06	3.94e-05	CcSEcCtD
Paroxetine—Dermatitis—Betaxolol—hypertension	6.29e-06	3.94e-05	CcSEcCtD
Paroxetine—Headache—Betaxolol—hypertension	6.26e-06	3.92e-05	CcSEcCtD
Paroxetine—Feeling abnormal—Lisinopril—hypertension	6.24e-06	3.91e-05	CcSEcCtD
Paroxetine—Gastrointestinal pain—Lisinopril—hypertension	6.19e-06	3.88e-05	CcSEcCtD
Paroxetine—Vomiting—Losartan—hypertension	6.19e-06	3.88e-05	CcSEcCtD
Paroxetine—Nausea—Perindopril—hypertension	6.16e-06	3.86e-05	CcSEcCtD
Paroxetine—Hypersensitivity—Ramipril—hypertension	6.15e-06	3.85e-05	CcSEcCtD
Paroxetine—Nausea—Irbesartan—hypertension	6.14e-06	3.85e-05	CcSEcCtD
Paroxetine—Rash—Losartan—hypertension	6.14e-06	3.84e-05	CcSEcCtD
Paroxetine—Dermatitis—Losartan—hypertension	6.13e-06	3.84e-05	CcSEcCtD
Paroxetine—Headache—Losartan—hypertension	6.1e-06	3.82e-05	CcSEcCtD
Paroxetine—Nausea—Hydrochlorothiazide—hypertension	6.09e-06	3.82e-05	CcSEcCtD
Paroxetine—Urticaria—Lisinopril—hypertension	6.01e-06	3.77e-05	CcSEcCtD
Paroxetine—Hypersensitivity—Timolol—hypertension	6.01e-06	3.77e-05	CcSEcCtD
Paroxetine—Nausea—Furosemide—hypertension	5.99e-06	3.75e-05	CcSEcCtD
Paroxetine—Asthenia—Ramipril—hypertension	5.99e-06	3.75e-05	CcSEcCtD
Paroxetine—Abdominal pain—Lisinopril—hypertension	5.98e-06	3.75e-05	CcSEcCtD
Paroxetine—Body temperature increased—Lisinopril—hypertension	5.98e-06	3.75e-05	CcSEcCtD
Paroxetine—Nausea—Betaxolol—hypertension	5.93e-06	3.72e-05	CcSEcCtD
Paroxetine—Pruritus—Ramipril—hypertension	5.9e-06	3.7e-05	CcSEcCtD
Paroxetine—Asthenia—Timolol—hypertension	5.85e-06	3.67e-05	CcSEcCtD
Paroxetine—Nausea—Losartan—hypertension	5.78e-06	3.62e-05	CcSEcCtD
Paroxetine—Pruritus—Timolol—hypertension	5.77e-06	3.62e-05	CcSEcCtD
Paroxetine—Diarrhoea—Ramipril—hypertension	5.71e-06	3.58e-05	CcSEcCtD
Paroxetine—Diarrhoea—Timolol—hypertension	5.58e-06	3.5e-05	CcSEcCtD
Paroxetine—Hypersensitivity—Lisinopril—hypertension	5.58e-06	3.49e-05	CcSEcCtD
Paroxetine—Dizziness—Ramipril—hypertension	5.52e-06	3.46e-05	CcSEcCtD
Paroxetine—Asthenia—Lisinopril—hypertension	5.43e-06	3.4e-05	CcSEcCtD
Paroxetine—Dizziness—Timolol—hypertension	5.39e-06	3.38e-05	CcSEcCtD
Paroxetine—Pruritus—Lisinopril—hypertension	5.35e-06	3.35e-05	CcSEcCtD
Paroxetine—Vomiting—Ramipril—hypertension	5.31e-06	3.32e-05	CcSEcCtD
Paroxetine—Rash—Ramipril—hypertension	5.26e-06	3.3e-05	CcSEcCtD
Paroxetine—Dermatitis—Ramipril—hypertension	5.26e-06	3.29e-05	CcSEcCtD
Paroxetine—Headache—Ramipril—hypertension	5.23e-06	3.27e-05	CcSEcCtD
Paroxetine—Vomiting—Timolol—hypertension	5.19e-06	3.25e-05	CcSEcCtD
Paroxetine—Diarrhoea—Lisinopril—hypertension	5.18e-06	3.24e-05	CcSEcCtD
Paroxetine—Rash—Timolol—hypertension	5.14e-06	3.22e-05	CcSEcCtD
Paroxetine—Dermatitis—Timolol—hypertension	5.14e-06	3.22e-05	CcSEcCtD
Paroxetine—Headache—Timolol—hypertension	5.11e-06	3.2e-05	CcSEcCtD
Paroxetine—Dizziness—Lisinopril—hypertension	5e-06	3.14e-05	CcSEcCtD
Paroxetine—Nausea—Ramipril—hypertension	4.96e-06	3.11e-05	CcSEcCtD
Paroxetine—Nausea—Timolol—hypertension	4.85e-06	3.04e-05	CcSEcCtD
Paroxetine—Vomiting—Lisinopril—hypertension	4.81e-06	3.01e-05	CcSEcCtD
Paroxetine—Rash—Lisinopril—hypertension	4.77e-06	2.99e-05	CcSEcCtD
Paroxetine—Dermatitis—Lisinopril—hypertension	4.77e-06	2.99e-05	CcSEcCtD
Paroxetine—Headache—Lisinopril—hypertension	4.74e-06	2.97e-05	CcSEcCtD
Paroxetine—Nausea—Lisinopril—hypertension	4.49e-06	2.82e-05	CcSEcCtD
Paroxetine—CHRM3—Metabolism—PIK3R1—hypertension	8.93e-07	9.82e-06	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—NOS3—hypertension	8.93e-07	9.82e-06	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—MMP9—hypertension	8.92e-07	9.8e-06	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—APOB—hypertension	8.91e-07	9.79e-06	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—CDKN1A—hypertension	8.88e-07	9.77e-06	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—PTEN—hypertension	8.86e-07	9.75e-06	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—AGT—hypertension	8.86e-07	9.74e-06	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—ADCY5—hypertension	8.84e-07	9.71e-06	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—APOB—hypertension	8.83e-07	9.71e-06	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—POMC—hypertension	8.81e-07	9.69e-06	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—GPX1—hypertension	8.81e-07	9.68e-06	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—INS—hypertension	8.76e-07	9.63e-06	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PRKCA—hypertension	8.72e-07	9.58e-06	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—CYP1A1—hypertension	8.72e-07	9.58e-06	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—CALM1—hypertension	8.71e-07	9.58e-06	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—APOE—hypertension	8.68e-07	9.55e-06	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—MAPK8—hypertension	8.67e-07	9.53e-06	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—GSTM1—hypertension	8.66e-07	9.53e-06	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—AKT1—hypertension	8.65e-07	9.51e-06	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—POMC—hypertension	8.64e-07	9.5e-06	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—CAV1—hypertension	8.6e-07	9.46e-06	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—POMC—hypertension	8.59e-07	9.45e-06	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—INS—hypertension	8.59e-07	9.44e-06	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—GSTM1—hypertension	8.59e-07	9.44e-06	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—APOA1—hypertension	8.58e-07	9.44e-06	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—CD36—hypertension	8.58e-07	9.43e-06	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—POMC—hypertension	8.56e-07	9.42e-06	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—INS—hypertension	8.54e-07	9.39e-06	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—MMP9—hypertension	8.54e-07	9.39e-06	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—INS—hypertension	8.52e-07	9.36e-06	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CDKN1A—hypertension	8.51e-07	9.35e-06	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—LPL—hypertension	8.5e-07	9.35e-06	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—PTEN—hypertension	8.49e-07	9.33e-06	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—POMC—hypertension	8.48e-07	9.33e-06	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—EP300—hypertension	8.45e-07	9.29e-06	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CCL2—hypertension	8.45e-07	9.29e-06	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—INS—hypertension	8.43e-07	9.27e-06	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—LPL—hypertension	8.43e-07	9.27e-06	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CCL2—hypertension	8.41e-07	9.24e-06	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CCL2—hypertension	8.38e-07	9.21e-06	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—ADCY5—hypertension	8.33e-07	9.15e-06	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—IGF1—hypertension	8.31e-07	9.14e-06	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—MAPK8—hypertension	8.3e-07	9.13e-06	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—AKT2—hypertension	8.3e-07	9.13e-06	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CCL2—hypertension	8.3e-07	9.12e-06	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—GPX1—hypertension	8.3e-07	9.12e-06	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—AKT1—hypertension	8.28e-07	9.1e-06	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—EGFR—hypertension	8.27e-07	9.09e-06	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—IGF1—hypertension	8.26e-07	9.09e-06	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—AKT2—hypertension	8.26e-07	9.08e-06	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—ADCY5—hypertension	8.25e-07	9.08e-06	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—IGF1—hypertension	8.24e-07	9.06e-06	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—AKT2—hypertension	8.23e-07	9.05e-06	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—GPX1—hypertension	8.23e-07	9.04e-06	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—EGFR—hypertension	8.22e-07	9.04e-06	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—SRC—hypertension	8.22e-07	9.04e-06	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—CYP1A1—hypertension	8.21e-07	9.03e-06	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PRKCA—hypertension	8.21e-07	9.03e-06	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—EGFR—hypertension	8.2e-07	9.01e-06	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—PTGS2—hypertension	8.17e-07	8.98e-06	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—IGF1—hypertension	8.16e-07	8.97e-06	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—AKT2—hypertension	8.15e-07	8.96e-06	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PRKCA—hypertension	8.14e-07	8.95e-06	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—CYP1A1—hypertension	8.14e-07	8.95e-06	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—MTHFR—hypertension	8.13e-07	8.93e-06	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—EGFR—hypertension	8.12e-07	8.93e-06	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—EP300—hypertension	8.09e-07	8.9e-06	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—CD36—hypertension	8.08e-07	8.88e-06	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—ALB—hypertension	8.03e-07	8.83e-06	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—CD36—hypertension	8.01e-07	8.81e-06	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—VEGFA—hypertension	8.01e-07	8.8e-06	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PPARA—hypertension	7.97e-07	8.77e-06	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—SERPINE1—hypertension	7.89e-07	8.68e-06	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—SRC—hypertension	7.87e-07	8.65e-06	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—SERPINE1—hypertension	7.85e-07	8.63e-06	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—SERPINE1—hypertension	7.82e-07	8.6e-06	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—SERPINE1—hypertension	7.75e-07	8.52e-06	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—AGT—hypertension	7.72e-07	8.49e-06	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—NOS3—hypertension	7.68e-07	8.45e-06	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—PIK3R1—hypertension	7.68e-07	8.45e-06	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—VEGFA—hypertension	7.67e-07	8.43e-06	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—MTHFR—hypertension	7.66e-07	8.42e-06	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—FGF2—hypertension	7.64e-07	8.4e-06	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—RHOA—hypertension	7.61e-07	8.37e-06	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—FGF2—hypertension	7.6e-07	8.35e-06	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—CALM1—hypertension	7.59e-07	8.35e-06	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—MTHFR—hypertension	7.59e-07	8.35e-06	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—FGF2—hypertension	7.57e-07	8.33e-06	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—RHOA—hypertension	7.57e-07	8.32e-06	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—APOE—hypertension	7.57e-07	8.32e-06	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—PPARG—hypertension	7.56e-07	8.32e-06	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—RHOA—hypertension	7.55e-07	8.3e-06	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—NOS3—hypertension	7.53e-07	8.28e-06	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—PIK3R1—hypertension	7.53e-07	8.28e-06	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PPARA—hypertension	7.51e-07	8.26e-06	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—FGF2—hypertension	7.5e-07	8.25e-06	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—CAV1—hypertension	7.5e-07	8.24e-06	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—PIK3R1—hypertension	7.49e-07	8.24e-06	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—NOS3—hypertension	7.49e-07	8.24e-06	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—APOA1—hypertension	7.48e-07	8.22e-06	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—RHOA—hypertension	7.47e-07	8.22e-06	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—NOS3—hypertension	7.47e-07	8.21e-06	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—PIK3R1—hypertension	7.47e-07	8.21e-06	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—POMC—hypertension	7.46e-07	8.2e-06	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PPARA—hypertension	7.45e-07	8.19e-06	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—INS—hypertension	7.42e-07	8.16e-06	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—PIK3R1—hypertension	7.4e-07	8.13e-06	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—NOS3—hypertension	7.4e-07	8.13e-06	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—MYC—hypertension	7.37e-07	8.1e-06	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—TGFB1—hypertension	7.35e-07	8.08e-06	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—AGT—hypertension	7.28e-07	8e-06	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—AGT—hypertension	7.21e-07	7.93e-06	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—EGFR—hypertension	7.2e-07	7.92e-06	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—CALM1—hypertension	7.15e-07	7.87e-06	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—APOE—hypertension	7.13e-07	7.84e-06	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—PTEN—hypertension	7.12e-07	7.83e-06	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—CALM1—hypertension	7.09e-07	7.8e-06	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—RELA—hypertension	7.09e-07	7.8e-06	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—APOE—hypertension	7.07e-07	7.77e-06	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—CAV1—hypertension	7.06e-07	7.77e-06	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—MYC—hypertension	7.05e-07	7.76e-06	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—RELA—hypertension	7.05e-07	7.75e-06	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—APOA1—hypertension	7.05e-07	7.75e-06	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—TGFB1—hypertension	7.04e-07	7.74e-06	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—RELA—hypertension	7.03e-07	7.73e-06	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—PTGS2—hypertension	7.03e-07	7.73e-06	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—CAV1—hypertension	7e-07	7.7e-06	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—APOA1—hypertension	6.99e-07	7.68e-06	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—RELA—hypertension	6.96e-07	7.65e-06	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—MTOR—hypertension	6.95e-07	7.65e-06	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—MTOR—hypertension	6.92e-07	7.6e-06	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—EGFR—hypertension	6.9e-07	7.59e-06	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—MTOR—hypertension	6.89e-07	7.58e-06	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—MTOR—hypertension	6.83e-07	7.51e-06	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—ALB—hypertension	6.8e-07	7.48e-06	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—EP300—hypertension	6.79e-07	7.47e-06	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CXCL8—hypertension	6.68e-07	7.35e-06	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CXCL8—hypertension	6.65e-07	7.31e-06	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CXCL8—hypertension	6.63e-07	7.28e-06	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PPARG—hypertension	6.59e-07	7.25e-06	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CXCL8—hypertension	6.56e-07	7.21e-06	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—PIK3R1—hypertension	6.51e-07	7.15e-06	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—NOS3—hypertension	6.51e-07	7.15e-06	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—POMC—hypertension	6.5e-07	7.15e-06	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—INS—hypertension	6.46e-07	7.11e-06	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—AKT1—hypertension	6.45e-07	7.1e-06	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—AKT1—hypertension	6.42e-07	7.06e-06	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—AKT1—hypertension	6.4e-07	7.04e-06	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—IL6—hypertension	6.35e-07	6.99e-06	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—AKT1—hypertension	6.34e-07	6.97e-06	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—IL6—hypertension	6.32e-07	6.95e-06	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—IL6—hypertension	6.3e-07	6.93e-06	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—IL6—hypertension	6.24e-07	6.86e-06	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PPARG—hypertension	6.21e-07	6.83e-06	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PPARG—hypertension	6.16e-07	6.77e-06	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—PTEN—hypertension	6.13e-07	6.74e-06	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—POMC—hypertension	6.12e-07	6.73e-06	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—INS—hypertension	6.09e-07	6.7e-06	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—POMC—hypertension	6.07e-07	6.68e-06	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—TP53—hypertension	6.05e-07	6.65e-06	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—MMP9—hypertension	6.04e-07	6.65e-06	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—INS—hypertension	6.04e-07	6.64e-06	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CDKN1A—hypertension	6.02e-07	6.62e-06	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—MMP9—hypertension	6.01e-07	6.61e-06	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—PTEN—hypertension	6.01e-07	6.61e-06	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—MMP9—hypertension	5.99e-07	6.59e-06	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CDKN1A—hypertension	5.99e-07	6.59e-06	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—PTEN—hypertension	5.98e-07	6.57e-06	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CDKN1A—hypertension	5.97e-07	6.57e-06	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—PTEN—hypertension	5.96e-07	6.55e-06	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—PTGS2—hypertension	5.95e-07	6.54e-06	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—MMP9—hypertension	5.93e-07	6.52e-06	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—ALB—hypertension	5.92e-07	6.51e-06	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CDKN1A—hypertension	5.91e-07	6.5e-06	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—PTEN—hypertension	5.9e-07	6.49e-06	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—MAPK8—hypertension	5.88e-07	6.46e-06	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—AKT1—hypertension	5.86e-07	6.45e-06	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—MAPK8—hypertension	5.85e-07	6.43e-06	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—EP300—hypertension	5.85e-07	6.43e-06	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—AKT1—hypertension	5.83e-07	6.41e-06	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—MAPK8—hypertension	5.83e-07	6.41e-06	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—AKT1—hypertension	5.81e-07	6.39e-06	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—TP53—hypertension	5.79e-07	6.37e-06	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—MAPK8—hypertension	5.77e-07	6.35e-06	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—AKT1—hypertension	5.76e-07	6.33e-06	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—EP300—hypertension	5.73e-07	6.3e-06	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—EP300—hypertension	5.7e-07	6.27e-06	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—EP300—hypertension	5.68e-07	6.25e-06	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PIK3R1—hypertension	5.67e-07	6.23e-06	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—NOS3—hypertension	5.67e-07	6.23e-06	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—EP300—hypertension	5.63e-07	6.19e-06	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—ALB—hypertension	5.58e-07	6.14e-06	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—SRC—hypertension	5.57e-07	6.13e-06	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—SRC—hypertension	5.54e-07	6.09e-06	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—IL6—hypertension	5.54e-07	6.09e-06	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—ALB—hypertension	5.54e-07	6.09e-06	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—SRC—hypertension	5.52e-07	6.07e-06	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—SRC—hypertension	5.47e-07	6.02e-06	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—VEGFA—hypertension	5.43e-07	5.97e-06	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—VEGFA—hypertension	5.4e-07	5.94e-06	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—VEGFA—hypertension	5.38e-07	5.92e-06	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PIK3R1—hypertension	5.34e-07	5.87e-06	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—NOS3—hypertension	5.34e-07	5.87e-06	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—VEGFA—hypertension	5.33e-07	5.86e-06	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—IL6—hypertension	5.3e-07	5.83e-06	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PIK3R1—hypertension	5.29e-07	5.82e-06	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—NOS3—hypertension	5.29e-07	5.82e-06	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—PTEN—hypertension	5.19e-07	5.71e-06	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PTGS2—hypertension	5.18e-07	5.7e-06	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—AKT1—hypertension	5.11e-07	5.62e-06	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—MYC—hypertension	4.99e-07	5.49e-06	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—TGFB1—hypertension	4.98e-07	5.48e-06	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—MYC—hypertension	4.97e-07	5.46e-06	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—TGFB1—hypertension	4.95e-07	5.45e-06	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—MYC—hypertension	4.95e-07	5.44e-06	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—EP300—hypertension	4.95e-07	5.44e-06	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—TGFB1—hypertension	4.94e-07	5.43e-06	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—MYC—hypertension	4.9e-07	5.39e-06	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—AKT1—hypertension	4.89e-07	5.38e-06	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—TGFB1—hypertension	4.89e-07	5.38e-06	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PTGS2—hypertension	4.88e-07	5.37e-06	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—EGFR—hypertension	4.88e-07	5.37e-06	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—EGFR—hypertension	4.86e-07	5.34e-06	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PTGS2—hypertension	4.84e-07	5.32e-06	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—EGFR—hypertension	4.84e-07	5.32e-06	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—EGFR—hypertension	4.8e-07	5.27e-06	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PTEN—hypertension	4.52e-07	4.97e-06	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—EP300—hypertension	4.31e-07	4.74e-06	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PTEN—hypertension	4.26e-07	4.68e-06	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PTEN—hypertension	4.22e-07	4.64e-06	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—AKT1—hypertension	4.11e-07	4.51e-06	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—TP53—hypertension	4.1e-07	4.51e-06	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—TP53—hypertension	4.08e-07	4.48e-06	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—TP53—hypertension	4.07e-07	4.47e-06	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—EP300—hypertension	4.06e-07	4.47e-06	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—EP300—hypertension	4.03e-07	4.43e-06	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—TP53—hypertension	4.03e-07	4.43e-06	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—IL6—hypertension	3.75e-07	4.13e-06	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—IL6—hypertension	3.73e-07	4.1e-06	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—IL6—hypertension	3.72e-07	4.09e-06	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—IL6—hypertension	3.69e-07	4.05e-06	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—AKT1—hypertension	3.53e-07	3.88e-06	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—AKT1—hypertension	3.46e-07	3.81e-06	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—AKT1—hypertension	3.44e-07	3.79e-06	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—AKT1—hypertension	3.43e-07	3.77e-06	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—AKT1—hypertension	3.4e-07	3.74e-06	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—AKT1—hypertension	2.99e-07	3.29e-06	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—AKT1—hypertension	2.61e-07	2.86e-06	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—AKT1—hypertension	2.46e-07	2.7e-06	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—AKT1—hypertension	2.43e-07	2.68e-06	CbGpPWpGaD
